Global Blood Stream Infection Testing Market 2016-2020

血流感染検査の世界市場2016-2020:ポイントオブケア検査(POCT)、核酸検査

◆タイトル:Global Blood Stream Infection Testing Market 2016-2020
◆商品コード:IRTNTR10736
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2016年11月9日
◆ページ数:82
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名利用)USD2,500 ⇒換算¥267,500見積依頼/購入/質問フォーム
Five User(~5名利用)USD3,000 ⇒換算¥321,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥428,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、血流感染検査の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、血流感染検査の世界市場規模及び予測、用途別分析、技術別分析、製品別分析、需要先別分析、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況などの情報をお届けいたします。

About Blood Stream Infection Testing
The presence of bacteria and fungi in blood leads to blood stream infections. Bacteria and fungi enter into the blood and cause severe complications and infections such as pneumonia, meningitis, sepsis and AIDS. Bloodstream infections are caused when bacteria enter the bloodstream; this may occur through a wound, injection, or through a surgical procedure. Symptoms of bacteremia may include fever, chills, malaise, nausea, diarrhea, shortness of breath, and vomiting.

Technavio’s analysts forecast the global blood stream infection testing market to grow at a CAGR of 7.75% during the period 2016-2020.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global blood stream infection testing market for 2016-2020. To calculate the market size, the report presents the vendor landscape and a corresponding detailed analysis of the top four vendors operating in the market.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Blood Stream Infection Testing Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• BD
• bioMérieux
• Cepheid
• Roche Diagnostics
• Thermo Fisher Scientific

[Other prominent vendors]
• IRIDICA
• Alere
• Beckman Coulter
• Bruker
• Nanosphere
• Siemens
• Dade Behring
• AdvanDX
• Eurogentec
• AB Sciex

[Market driver]
• Growing awareness of blood donation increasing the demand for BSI testing market.
• For a full, detailed list, view our report

[Market challenge]
• Lack of favorable reimbursement reduces adoption rate among patients.
• For a full, detailed list, view our report

[Market trend]
• Increasing demand for infection control committee in hospitals.
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 06: Market segmentation by product
• Market overview
• Instruments
• Consumables (blood culture bottles, reagents and assay kits)

PART 07: Market segmentation by application
• Bacteremia
• Fungemia
• Mycobacteria

PART 08: Market segmentation by technology
• Market overview
• Conventional blood stream infection test
• Point of care testing (POCT)
• Nucleic acid testing

PART 09: Market segmentation by end-user
• Hospitals
• Diagnostic clinical laboratories

PART 10: Geographical segmentation
• Blood stream infection market in Americas
• Blood stream infection tests market in EMEA
• Blood stream infection tests market in APAC

PART 11: Market drivers
• Rising incidence of hospital acquired infection increases patient volume
• Patient-centered healthcare by digital technology
• Growing awareness of blood donation increasing the demand for BSI testing market

PART 12: Impact of drivers

PART 13: Market challenges
• High cost of instruments restricts market growth
• Lack of favorable reimbursement reduces adoption rate among patients
• Stringent regulatory policies restrict entry of new technologies

PART 14: Impact of drivers and challenges

PART 15: Market trends
• Focus on early diagnosis
• Technologically advanced tests save time and cost
• Increasing demand for infection control committee in hospitals

PART 16: Vendor landscape
• Competitive scenario
• BD
• bioMérieux
• Cepheid
• Roche Diagnostics
• Thermo Fisher Scientific
• Other prominent vendors

PART 17: Appendix
• List of abbreviations

PART 18: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Mortality rate of community acquired blood stream infections per year in different regions
Exhibit 03: Global blood stream infection testing market 2015-2020 ($ millions)
Exhibit 04: Global blood stream infection testing market overview
Exhibit 05: Five forces analysis
Exhibit 06: Global blood stream infection testing market by products 2015-2020 (%)
Exhibit 07: Market strategy analysis of instruments segment
Exhibit 08: Global blood stream infection testing instruments market 2015-2020 ($ millions)
Exhibit 09: Market strategy analysis of consumable segment
Exhibit 10: Global blood stream infection testing consumables market 2015-2020 ($ millions)
Exhibit 11: Top ten bacterimia blood stream infections in 2015
Exhibit 12: Global blood stream infections testing market by products
Exhibit 13: Global blood stream infection testing market share by technology 2015-2020 (%)
Exhibit 14: Global conventional blood stream infection testing market 2015-2020 ($ millions)
Exhibit 15: The laboratory and POC testing process
Exhibit 16: Global blood stream infection testing market by end-user 2015-2020 (%)
Exhibit 17: Blood stream infection testing market revenue in the Americas 2015-2020 ($ millions)
Exhibit 18: Blood stream infection testing market in Americas
Exhibit 19: Blood stream infection testing market revenue in EMEA 2015-2020 ($ millions)
Exhibit 20: Blood stream infection testing market in EMEA
Exhibit 21: Blood stream infection testing market revenue in APAC 2015-2020 ($ millions)
Exhibit 22: Blood stream infection testing market in APAC
Exhibit 23: Impact of driver
Exhibit 24: Price of different sequencers of different companies
Exhibit 25: Government regulatory stages of blood stream infection devices and consumables
Exhibit 26: Impact of drivers and challenges
Exhibit 27: Reasons for hospital acquired blood stream infection
Exhibit 28: Competitive structure of vendors in blood stream infection testing market
Exhibit 29: Strength assessment
Exhibit 30: BD: Strategy assessment
Exhibit 31: BD opportunity assessment
Exhibit 32: bioMérieux strength assessment
Exhibit 33: bioMérieux strategy assessment
Exhibit 34: bioMérieux: Opportunity assessment
Exhibit 35: Cepheid: Strength assessment
Exhibit 36: Cepheid: Strategy assessment
Exhibit 37: Cepheid opportunity assessment
Exhibit 38: Roche Diagnostics: Strength assessment
Exhibit 39: Roche Diagnostics: Strategy assessment
Exhibit 40: Roche Diagnostics: Opportunity assessment
Exhibit 41: Thermo Fisher Scientific: Strength assessment
Exhibit 42: Thermo Fisher Scientific: Strategy assessment
Exhibit 43: Thermo Fisher Scientific: Opportunity assessment



【掲載企業】

BD, bioMérieux, Cepheid, Roche Diagnostics, Thermo Fisher, IRIDICA, Alere, Beckman Coulter, Bruker, Nanosphere, Siemens, Dade Behring, AdvanDX, Eurogentec, AB Sciex.

【資料のキーワード】

血流感染検査、ポイントオブケア検査(POCT)、核酸検査

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[血流感染検査の世界市場2016-2020:ポイントオブケア検査(POCT)、核酸検査] (Global Blood Stream Infection Testing Market 2016-2020 / IRTNTR10736)販売に関する免責事項
[血流感染検査の世界市場2016-2020:ポイントオブケア検査(POCT)、核酸検査] (Global Blood Stream Infection Testing Market 2016-2020 / IRTNTR10736)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆